Navigation Links
Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
Date:6/1/2009

nd 26.6 mg famotidine) or ibuprofen (800 mg) alone who developed endoscopically diagnosed gastric and/or duodenal ulcers during a 24-week treatment period. The results for each study were analyzed using both life-table and crude-rate statistical methods. Results are listed in the table below:

                REDUCE 1 (n=812)                REDUCE 2 (n=570)

               HZT-501   Ibuprofen   P-value   HZT-501   Ibuprofen   P-value
               (n=550)   (n=262)              (n=380)    (n=190)

    No. of
     patients
     developing
     upper GI
     ulcers        62        61                    40        38
    Life Table
     Analysis(%) 14.7      29.1    0.0002        13.8      22.6       0.0304
    Crude Rate
     Analysis(%) 11.3      23.3    0.0001        10.5        20       0.0018


Treatment with HZT-501 was well-tolerated. The most commonly reported adverse events in these two studies were dyspepsia, nausea, diarrhea, constipation, headache and upper respiratory tract infection. The majority were mild to moderate in severity. There were no significant differences in adverse event or serious adverse event profiles between the two treatment groups. One death occurred in the ibuprofen group due to an overdose of Tylenol(R).

"Patients treated with HZT-501 were approximately half as likely to develop upper GI ulcers compared to patients treated with ibuprofen alone," said Timothy P. Walbert, president and chief executive officer of Horizon Therapeutics. "These data provide compelling evidence for the promise of HZT-501 in treating patients with mild to moderate pain who are at risk for upper GI ulcers."

NSAIDs, such as ibuprofen, are among the most widely used drugs in the world for the treatment of chronic pain and inflammation with more than 90 million prescriptions written each year for the treatment of arthritis and other types of mild-to-moderate pain.
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
2. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
3. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
4. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
5. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
6. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FOREST, Ill. , March 6, 2015   Hospira, ... the U.S. Food and Drug Administration (FDA) on today,s FDA ... States . This is a watershed moment for improving ... As a leading global provider of biosimilars, Hospira has seen ... we are a proud participant in these early stages of ...
(Date:3/6/2015)... , March 6, 2015  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... for Veterinary Biologicals of the U.S. Department of Agriculture ... for the detection of   A. phagocytophelium and ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... data demonstrating that diagnostic tests that use increasing numbers ... dramatically reduce the specificity of test results, leading to ... are erroneously diagnosed as cancerous. In addition, these new ... of the malignancies leading to "false negatives." The data ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... The American Pharmacists Association would like to remind ... pharmacist during cold and flu season. A pharmacist can ... shot, identifying the differences between a common cold and ... a recommendation when a health care provider should be ...
... LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 ... of Hackensack, N.J., announced today they have signed an ... range of Genesis-branded products for blood centers, plasma centers ... The agreement covers products such as Genesis™ blood ...
Cached Medicine Technology:Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 2Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 3Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products 2
(Date:3/6/2015)... (PRWEB) March 06, 2015 Follow ... of the most common forms of cancer and is ... cancer can be screened through various techniques and tools, ... however remains the gold standard technique in breast cancer ... cost, time taken for the procedure, required expertise to ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... exchange has extended their customer appreciation discount code ED-SHEERAN-2015 for ... Yorkshire England and he began his career in the music ... couple of years Ed Sheeran has become a household name. ... on stage he is having the time of his life ...
(Date:3/6/2015)... Further solidifying their position as a ... announced today that the company has earned Inavero’s Best ... of Staffing Talent Award five years in a row. ... Talent Diamond winners are proven industry leaders in service ... the individuals they have helped find temporary and permanent ...
(Date:3/6/2015)... Since Medicare began paying for chronic ... been an overwhelming demand from providers for straightforward guidance ... program. The Centers for Medicare & Medicaid Services ... PYA’s updated white paper—“ Providing and Billing Medicare for ... detailed, yet practical “how to” manual for providers looking ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
Breaking Medicine News(10 mins):Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... with a low prevalence of tuberculosis (TB), the majority ... the U.S for the diagnosis of TB are ... "We compared commercially available tests for latent tuberculosis infection ... prevalence," said James Mancuso, MD, DrPH, of the Walter ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Increased consumption ... of breast cancer recurrence, new research finds. Researcher ... University of California, San Diego, looked at changes in ... potatoes, that breast cancer survivors ate over a one-year ...
... By Kathleen Doheny HealthDay Reporter , ... breast reconstruction after a mastectomy, despite the known cosmetic ... immediate reconstruction rates are higher in women with DCIS ... with invasive cancer," said Dr. Dawn Hershman, an associate ...
... ANTONIO -- Precisely quantifying the amount of three different ... linked to breast cancer , did not predict ... Cancer with Herceptin, say Mayo Clinic researchers. HER2-positive ... human epidermal growth factor receptor 2 that promotes cancer ...
... , THURSDAY, Dec. 8 (HealthDay News) -- New ... States should significantly shorten and simplify the course of the ... the U.S. Centers for Disease Control and Prevention. The ... -- which are based on expert opinion and the results ...
... HealthDay Reporter , THURSDAY, Dec. 8 (HealthDay News) -- ... about 22 percent in people with prehypertension who took drugs ... high blood pressure, but they still benefited from taking the ... of heart attacks for people taking antihypertensives. "We know ...
Cached Medicine News:Health News:Discordance among commercially-available diagnostics for latent TB infection 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 3Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 2Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 3Health News:Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer 2Health News:CDC Issues New TB Treatment Guidelines 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 3
The NPT7 blood gas analyzer measures pH/blood gases and oximetry on 90 L sample volume with a two-step sampling procedure. Clinical tests compare NPT7 accuracy to that of benchtop analyzers. 30 sampl...
... GEM Premier 3000 simplifies and ... addition to unique features such ... and comprehensive menu options, the ... Intelligent Quality Management (iQM), an ...
... IRMA TRUpoint sets the standard for ... chemistries right at your patient's side ... This powerful, self contained system can ... CCU to ICU, or wherever you ...
Mini-flatbed agitator....
Medicine Products: